Author： Hägg Staffan Jönsson Anna K Spigset Olav
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.8, Iss.5, 2009-09, pp. : 537-547
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Assessment of the Risk for Venous Thromboembolism Among Users of Hormone Replacement Therapy
By Oger E.
Drugs & Aging, Vol. 14, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
Antipsychotic-Induced Venous Thromboembolism: A Review of the Evidence
By Hägg S.
CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. :
Bevacizumab: increased risk of venous thromboembolism
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :
Bevacizumab: increased risk of venous thromboembolism
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :